News

According to AstraZeneca, Cediranib met the co-primary endpoint of improving progression-free survival (PFS) but showed no improvement in overall survival (OS). AstraZeneca said that the adverse events associated

According to Applied BioCode, the CE Certification for the BioCode-1000 Analyzer proves that the anlyzer has met all relevant European Union consumer safety requirements. The CE Mark will

China Sky One Medical said that the new certificate will be valid until May 2015. Reportedly, SFDA’s examination committee had visited Tian Long in April to review its

The outcome of the trail has been notified to the investigators involved in the study and to the regulatory agencies. It has not noticed any new or unexpected

The new joint venture will be held at 51% by sanofi-aventis and at 49% by Nichi-Iko. In addition, sanofi-aventis is expected to acquire 1,524,500 shares of Nichi-Iko, to

The recalled products were manufactured for Blacksmith Brands by McNeil Consumer Healthcare, a Division of McNeil-PPC, (a Johnson & Johnson company) at McNeil’s Fort Washington, Pennsylvania plant. FDA

Advaxis said that the study is designed to assess the safety and efficacy of ADXS11-001, for the treatment of CIN grade 2/3 commonly known as cervical dysplasia. Reportedly,

Celsis helps customers with their filings by offering various resources including the assistance of regulatory compliance manager. The DMF is a technical document that contains reference support data

Ferinject is an intravenous (iv) iron product used to treat iron deficiency and iron deficiency anaemia. Vifor Pharma said that the authors of the FAIR-HF studied the effects